Loading...
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most pressing medical and socioeconomic challenge. Constituting important correlates of protection, the determination of virus-neutralizing antibodies (NAbs) is indispe...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7581787/ https://ncbi.nlm.nih.gov/pubmed/33162987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.573526 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|